Effect of Rhaza stricta on the developing rat fetus

Rasheed A. Rasheed, Ahmed K. Bashir, Badreldin H. Ali, Rengasamy Padmanabhan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Rhazya stricta is a medicinal plant traditionally used in the treatment of diabetes mellitus, inflammation, and helminthiasis. Our objective was to determine if the plant extract has any effect on fetal development in the rat. A lyophilized extract of the plant was administered daily on three consecutive gestation days (GD) covering the period of preimplantation and organogenesis. The fetuses were examined on GD 20. Higher doses (5.0 or 8.0 g/kg) of R. stricta generally caused a reduction in maternal weight gain, compared to controls, whereas the lower doses (0.5 to 2.0 g/kg) did not. Treatment on GD 1, 2, 3, or 7, 8, 9 had no effect on the fetal weight. Treatment on later days GD 8, 9, 10, or 10, 11, 12, or 13, 14, 15 reduced both the number of live fetuses and their weight. Pronounced intrauterine growth retardation (IUGR) was observed in groups treated at later stages, particularly in the high dose groups. Extreme resorption characterized R. stricta treatment on GD 10, 11, and 12. Examination of the conceptus 24 h after R. stricta treatment indicated retarded placental development associated with hypovascularity, which possibly contributed to the IUGR and fetal death. The incidence of malformations such as micromelia, adactyly, maxillary-mundibular hypoplasia, protruding tongue, and edema, did not reach statistical significance. Except perhaps for a generalized growth retardation, no skeletal malformations were obvious. These observations are suggestive of potential fetal toxicity of R. stricta if taken during pregnancy.

Original languageEnglish
Pages (from-to)191-199
Number of pages9
JournalReproductive Toxicology
Volume11
Issue number2-3
DOIs
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Rats
Fetus
Plant Extracts
Pregnancy
Fetal Growth Retardation
Medical problems
Toxicity
Apocynaceae
Helminthiasis
Placentation
Fetal Weight
Fetal Death
Organogenesis
Medicinal Plants
Fetal Development
Tongue
Weight Gain
Edema
Diabetes Mellitus
Mothers

Keywords

  • cut fetuses
  • growth retardation
  • placental abnormalities
  • Rhazya stricta
  • teratogenicity

ASJC Scopus subject areas

  • Toxicology

Cite this

Effect of Rhaza stricta on the developing rat fetus. / Rasheed, Rasheed A.; Bashir, Ahmed K.; Ali, Badreldin H.; Padmanabhan, Rengasamy.

In: Reproductive Toxicology, Vol. 11, No. 2-3, 1997, p. 191-199.

Research output: Contribution to journalArticle

Rasheed, Rasheed A. ; Bashir, Ahmed K. ; Ali, Badreldin H. ; Padmanabhan, Rengasamy. / Effect of Rhaza stricta on the developing rat fetus. In: Reproductive Toxicology. 1997 ; Vol. 11, No. 2-3. pp. 191-199.
@article{deb364cc10cf4fba954718aae197bf2c,
title = "Effect of Rhaza stricta on the developing rat fetus",
abstract = "Rhazya stricta is a medicinal plant traditionally used in the treatment of diabetes mellitus, inflammation, and helminthiasis. Our objective was to determine if the plant extract has any effect on fetal development in the rat. A lyophilized extract of the plant was administered daily on three consecutive gestation days (GD) covering the period of preimplantation and organogenesis. The fetuses were examined on GD 20. Higher doses (5.0 or 8.0 g/kg) of R. stricta generally caused a reduction in maternal weight gain, compared to controls, whereas the lower doses (0.5 to 2.0 g/kg) did not. Treatment on GD 1, 2, 3, or 7, 8, 9 had no effect on the fetal weight. Treatment on later days GD 8, 9, 10, or 10, 11, 12, or 13, 14, 15 reduced both the number of live fetuses and their weight. Pronounced intrauterine growth retardation (IUGR) was observed in groups treated at later stages, particularly in the high dose groups. Extreme resorption characterized R. stricta treatment on GD 10, 11, and 12. Examination of the conceptus 24 h after R. stricta treatment indicated retarded placental development associated with hypovascularity, which possibly contributed to the IUGR and fetal death. The incidence of malformations such as micromelia, adactyly, maxillary-mundibular hypoplasia, protruding tongue, and edema, did not reach statistical significance. Except perhaps for a generalized growth retardation, no skeletal malformations were obvious. These observations are suggestive of potential fetal toxicity of R. stricta if taken during pregnancy.",
keywords = "cut fetuses, growth retardation, placental abnormalities, Rhazya stricta, teratogenicity",
author = "Rasheed, {Rasheed A.} and Bashir, {Ahmed K.} and Ali, {Badreldin H.} and Rengasamy Padmanabhan",
year = "1997",
doi = "10.1016/S0890-6238(97)00006-3",
language = "English",
volume = "11",
pages = "191--199",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Inc.",
number = "2-3",

}

TY - JOUR

T1 - Effect of Rhaza stricta on the developing rat fetus

AU - Rasheed, Rasheed A.

AU - Bashir, Ahmed K.

AU - Ali, Badreldin H.

AU - Padmanabhan, Rengasamy

PY - 1997

Y1 - 1997

N2 - Rhazya stricta is a medicinal plant traditionally used in the treatment of diabetes mellitus, inflammation, and helminthiasis. Our objective was to determine if the plant extract has any effect on fetal development in the rat. A lyophilized extract of the plant was administered daily on three consecutive gestation days (GD) covering the period of preimplantation and organogenesis. The fetuses were examined on GD 20. Higher doses (5.0 or 8.0 g/kg) of R. stricta generally caused a reduction in maternal weight gain, compared to controls, whereas the lower doses (0.5 to 2.0 g/kg) did not. Treatment on GD 1, 2, 3, or 7, 8, 9 had no effect on the fetal weight. Treatment on later days GD 8, 9, 10, or 10, 11, 12, or 13, 14, 15 reduced both the number of live fetuses and their weight. Pronounced intrauterine growth retardation (IUGR) was observed in groups treated at later stages, particularly in the high dose groups. Extreme resorption characterized R. stricta treatment on GD 10, 11, and 12. Examination of the conceptus 24 h after R. stricta treatment indicated retarded placental development associated with hypovascularity, which possibly contributed to the IUGR and fetal death. The incidence of malformations such as micromelia, adactyly, maxillary-mundibular hypoplasia, protruding tongue, and edema, did not reach statistical significance. Except perhaps for a generalized growth retardation, no skeletal malformations were obvious. These observations are suggestive of potential fetal toxicity of R. stricta if taken during pregnancy.

AB - Rhazya stricta is a medicinal plant traditionally used in the treatment of diabetes mellitus, inflammation, and helminthiasis. Our objective was to determine if the plant extract has any effect on fetal development in the rat. A lyophilized extract of the plant was administered daily on three consecutive gestation days (GD) covering the period of preimplantation and organogenesis. The fetuses were examined on GD 20. Higher doses (5.0 or 8.0 g/kg) of R. stricta generally caused a reduction in maternal weight gain, compared to controls, whereas the lower doses (0.5 to 2.0 g/kg) did not. Treatment on GD 1, 2, 3, or 7, 8, 9 had no effect on the fetal weight. Treatment on later days GD 8, 9, 10, or 10, 11, 12, or 13, 14, 15 reduced both the number of live fetuses and their weight. Pronounced intrauterine growth retardation (IUGR) was observed in groups treated at later stages, particularly in the high dose groups. Extreme resorption characterized R. stricta treatment on GD 10, 11, and 12. Examination of the conceptus 24 h after R. stricta treatment indicated retarded placental development associated with hypovascularity, which possibly contributed to the IUGR and fetal death. The incidence of malformations such as micromelia, adactyly, maxillary-mundibular hypoplasia, protruding tongue, and edema, did not reach statistical significance. Except perhaps for a generalized growth retardation, no skeletal malformations were obvious. These observations are suggestive of potential fetal toxicity of R. stricta if taken during pregnancy.

KW - cut fetuses

KW - growth retardation

KW - placental abnormalities

KW - Rhazya stricta

KW - teratogenicity

UR - http://www.scopus.com/inward/record.url?scp=0030615251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030615251&partnerID=8YFLogxK

U2 - 10.1016/S0890-6238(97)00006-3

DO - 10.1016/S0890-6238(97)00006-3

M3 - Article

VL - 11

SP - 191

EP - 199

JO - Reproductigve Toxicoloy

JF - Reproductigve Toxicoloy

SN - 0890-6238

IS - 2-3

ER -